Mary Tagliaferri
Net Worth

Last updated:

What is Mary Tagliaferri net worth?

Unfortunately, the net worth of Dr. Mary Tagliaferri is not known at this time.

Nektar Therapeutics key executives

Nektar Therapeutics executives and other stock owners filed with the SEC:

  • Dr. Brian L. Kotzin Senior Vice President of Clinical Devel. & Head of Immunology Program
  • Dr. Jonathan Zalevsky (50) Chief R&D Officer
  • Dr. Kevin Brodbeck Senior Vice President of Manufacturing
  • Dr. Mary Tagliaferri Senior Vice President & Executive Clinical Fellow
  • Mr. Gilbert M. Labrucherie (53) Senior Vice President, Chief Financial Officer & Chief Operating Officer
  • Mr. Howard W. Robin (72) Chief Executive Officer, Pres & Director
  • Mr. John P. Northcott (47) Senior Vice President & Chief Commercial Officer
  • Mr. Mark A. Wilson Senior Vice President, Gen. Counsel & Sec.
  • Ms. Jennifer Ruddock Senior Vice President of Strategy & Corporation Affairs
  • Ms. Jillian B. Thomsen (59) Senior Vice President of Fin. & Chief Accounting Officer